Waters Stock Takes a Hit After Strong Q4, Blames Murky 2024 Forecast
Revolutionizing Biopharma: Waters Unveils Breakthrough Charge Detection Mass Spectrometry for Next-Gen Therapies
Waters Corporation's Risky Plunge: Is the Wyatt Acquisition Weakening Its Core Strength?